01 10Osler, Hoskin & Harcourt LLP
01 22646437
02 22696776
03 22696807
04 22755976
05 22761940
01 10QUIZARTINIB HYDROCHLORIDE
01 10TABLET
01 21930-03-22
02 21930-05-14
03 22027-03-16
04 22028-09-19
05 22028-11-07
Patent Expiration Date : 2027-03-16
Date Granted : 2016-05-17
Brand Name : VANFLYTA
Patent Number : 2646437
Filing Date : 2007-03-16
Strength per Unit : 17.7mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-03-16
Date Granted : 2016-05-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-09-19
Date Granted : 2015-12-15
Brand Name : VANFLYTA
Patent Number : 2696776
Filing Date : 2008-09-19
Strength per Unit : 17.7mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-09-19
Date Granted : 2015-12-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 1930-03-22
Date Granted : 2020-04-07
Brand Name : VANFLYTA
Patent Number : 2755976
Filing Date : 2010-03-22
Strength per Unit : 17.7mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1930-03-22
Date Granted : 2020-04-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 1930-05-14
Date Granted : 2018-04-10
Brand Name : VANFLYTA
Patent Number : 2761940
Filing Date : 2010-05-14
Strength per Unit : 17.7mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1930-05-14
Date Granted : 2018-04-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-03-16
Date Granted : 2016-05-17
Brand Name : VANFLYTA
Patent Number : 2646437
Filing Date : 2007-03-16
Strength per Unit : 26.5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-03-16
Date Granted : 2016-05-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-09-19
Date Granted : 2015-12-15
Brand Name : VANFLYTA
Patent Number : 2696776
Filing Date : 2008-09-19
Strength per Unit : 26.5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-09-19
Date Granted : 2015-12-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-11-07
Date Granted : 2017-11-28
Brand Name : VANFLYTA
Patent Number : 2696807
Filing Date : 2008-11-07
Strength per Unit : 26.5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-07
Date Granted : 2017-11-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 1930-03-22
Date Granted : 2020-04-07
Brand Name : VANFLYTA
Patent Number : 2755976
Filing Date : 2010-03-22
Strength per Unit : 26.5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1930-03-22
Date Granted : 2020-04-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 1930-05-14
Date Granted : 2018-04-10
Brand Name : VANFLYTA
Patent Number : 2761940
Filing Date : 2010-05-14
Strength per Unit : 26.5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1930-05-14
Date Granted : 2018-04-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-11-07
Date Granted : 2017-11-28
Brand Name : VANFLYTA
Patent Number : 2696807
Filing Date : 2008-11-07
Strength per Unit : 17.7mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-07
Date Granted : 2017-11-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
